Latest Breaking News On - Vitreoretinal associates - Page 1 : comparemela.com

Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World Congress

/PRNewswire/ Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today.

United statesUniversity of south floridaFort lauderdalePeter kaiserChristine kaySamuel baroneSamarendra mohantyPrnewswire nanoscope therapeutics incRetina world congressNanoscope therapeutics incClinical trials at vitreoretinal associatesFort lauderdale marriott harbor beach hotelTherapeutics incMulti characteristic opsinPoster numberWednesday posters

Geographic Atrophy Treatment Breakthrough, Strengthened Doses Headline Historic 2023 for Ophthalmology

Chief among a flurry of clinical advances in retina disease this year were the FDA approvals of complement inhibitors for GA and a higher-dose aflibercept for diabetic retinopathy. What comes next?

United statesStanford universityCleveland clinicChristinen kayIapocec hani salehi hadIapocec apellisIapocec aleksandra rachitskayaIapocec jean francois korobelnikW lloyd clarkMarcoa zarbinIapocec charles wykoffIapocec dianaArshad khananiAleksandra rachitskayaIapocec arshad khananiCampbellp aflibercept

Christine N Kay, MD: Results of TEASE-1 Study on Stargardt Disease

At AAO 2023, Kay shares insight into the topline results of the TEASE-1 study investigating the effect of gildeuretinol (ALK-001) on the inherited retinal disease.

United statesSan franciscoChristinen kayVitreoretinal associates in gainesvilleDrug administrationAmerican academy of ophthalmologyStargardt diseaseAnnual american academyVitreoretinal associatesStargardt macularBreakthrough therapy designationOrphan drug designation

Kiora Pharmaceuticals and the Choroideremia Research Foundation to Host Webinar on the Development of Molecular Photoswitches for Inherited Retinal Diseases

Kiora Pharmaceuticals and the Choroideremia Research Foundation to Host Webinar on the Development of Molecular Photoswitches for Inherited Retinal Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Christine kayEric danielsVitreoretinal associatesKiora pharmaceuticalsChoroideremia research foundationCalifornia newsfile corpLive eventHeld thursdayVitreoretinal surgeonChief development officerInherited retinal disease webinarInvestor relationsMolecular photoswitchesRetinitis pigmentosaDihydroorotate dehydrogenasePrivate securities litigation reform act

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals and the Choroideremia Research Foundation to Host Webinar on the Development of Molecular Photoswitches for Inherited Retinal Diseases

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals and the Choroideremia Research Foundation to Host Webinar on the Development of Molecular Photoswitches for Inherited Retinal Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Christine kayEric danielsChoroideremia research foundationVitreoretinal associatesKiora pharmaceuticalsCalifornia newsfile corpLive eventHeld thursdayVitreoretinal surgeonChief development officerInherited retinal disease webinarInvestor relationsMolecular photoswitchesRetinitis pigmentosaDihydroorotate dehydrogenasePrivate securities litigation reform act